<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:media="http://search.yahoo.com/mrss/"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Novartis &#8211; InfoStride News</title>
	<atom:link href="https://www.theinfostride.com/tag/novartis/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.theinfostride.com</link>
	<description>Breaking News, Nigeria News and Top Stories</description>
	<lastBuildDate>Tue, 22 Apr 2014 06:11:43 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://www.theinfostride.com/wp-content/uploads/2015/07/cropped-The-InfoStride-Favicon-150x150.png</url>
	<title>Novartis &#8211; InfoStride News</title>
	<link>https://www.theinfostride.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>US pharmaceutical giant  Eli Lilly to buy part of Novartis for $5.4 bn</title>
		<link>https://www.theinfostride.com/us-pharmaceutical-giant-eli-lilly-to-buy-part-of-novartis-for-5-4-bn/</link>
		
		<dc:creator><![CDATA[Ade Adewale]]></dc:creator>
		<pubDate>Tue, 22 Apr 2014 06:11:43 +0000</pubDate>
				<category><![CDATA[Business & Economy News]]></category>
		<category><![CDATA[US News]]></category>
		<category><![CDATA[AFP]]></category>
		<category><![CDATA[energy giant]]></category>
		<category><![CDATA[giant]]></category>
		<category><![CDATA[Novartis]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[Switzerland]]></category>
		<category><![CDATA[US]]></category>
		<guid isPermaLink="false">http://www.theinfostride.com/?p=37508</guid>

					<description><![CDATA[<p>US pharmaceutical giant Eli Lilly said Tuesday it has reached an agreement to acquire the animal health division of Novartis of Switzerland for $5.4 billion (3.9 billion euros). In a statement Eli Lilly said the deal will strengthen and diversify its&#8230;</p>
<p>Source from <a rel="nofollow" href="https://www.theinfostride.com">InfoStride News</a></p>
]]></description>
		
		
		
		<media:content url="https://www.theinfostride.com/wp-content/uploads/2014/04/repost-us-12010449.jpg" medium="image"></media:content>
            	</item>
		<item>
		<title>Novartis replaces top Japan executives over drug trial scandal</title>
		<link>https://www.theinfostride.com/novartis-replaces-top-japan-executives-over-drug-trial-scandal/</link>
		
		<dc:creator><![CDATA[Ade Adewale]]></dc:creator>
		<pubDate>Thu, 03 Apr 2014 06:38:40 +0000</pubDate>
				<category><![CDATA[Asian News]]></category>
		<category><![CDATA[Business & Economy News]]></category>
		<category><![CDATA[AFP]]></category>
		<category><![CDATA[David]]></category>
		<category><![CDATA[drug]]></category>
		<category><![CDATA[Japan]]></category>
		<category><![CDATA[Novartis]]></category>
		<category><![CDATA[Swiss pharmaceutical]]></category>
		<guid isPermaLink="false">http://www.theinfostride.com/?p=32722</guid>

					<description><![CDATA[<p>Swiss pharmaceutical giant Novartis said on Thursday it was replacing the top executives at its Japanese unit over allegations the division hid serious potential side effects of leukaemia treatments from regulators. David Epstein, the head of the firm&#8230;</p>
<p>Source from <a rel="nofollow" href="https://www.theinfostride.com">InfoStride News</a></p>
]]></description>
		
		
		
		<media:content url="https://www.theinfostride.com/wp-content/uploads/2014/04/repost-us-11306883.jpg" medium="image"></media:content>
            	</item>
		<item>
		<title>Japan&#8217;s health ministry to file criminal complaint against Novartis</title>
		<link>https://www.theinfostride.com/japans-health-ministry-to-file-criminal-complaint-against-novartis/</link>
		
		<dc:creator><![CDATA[Ade Adewale]]></dc:creator>
		<pubDate>Tue, 07 Jan 2014 22:36:36 +0000</pubDate>
				<category><![CDATA[Asian News]]></category>
		<category><![CDATA[drug]]></category>
		<category><![CDATA[health ministry]]></category>
		<category><![CDATA[Japan]]></category>
		<category><![CDATA[Japanese News]]></category>
		<category><![CDATA[Novartis]]></category>
		<category><![CDATA[Swiss pharmaceutical]]></category>
		<guid isPermaLink="false">http://www.theinfostride.com/?p=8925</guid>

					<description><![CDATA[<p>Japan's health ministry will Wednesday file a criminal complaint against the local arm of Swiss pharmaceutical giant Novartis over alleged exaggerated advertising for a popular blood-pressure drug, Kyodo News agency reported. Novartis Pharma KK has&#8230;</p>
<p>Source from <a rel="nofollow" href="https://www.theinfostride.com">InfoStride News</a></p>
]]></description>
		
		
		
		<media:content url="https://www.theinfostride.com/wp-content/uploads/2014/01/repost-us-9670986.jpg" medium="image"></media:content>
            	</item>
	</channel>
</rss>
